ID
38587
Beschrijving
Study ID: 110951 Clinical Study ID: 110951 Study Title: A two-part, randomised, placebo-controlled study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of single doses of intravenously infused GSK1995057 in healthy subjects. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01476046 See https://clinicaltrials.gov/ct2/show/NCT01476046 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: N/A, Placebo Trade Name: N/A Study Indication: Respiratory Disorders This phase I trial primarily studies the safety and tolerability of ascending single intravenous doses of the selective TNFR1 antagonist GSK1995057 in healthy volunteers, and secondly explores the drug's pharmacodynamics, pharmacokinetics, concentration in lung epithelial lining fluid as well as its effect on immune system markers. The drug is hypothesized to be useful for Acute Lung Injury. The single-centre study consists of two parts A and B with seven cohorts/ten subcohorts in total. Part A includes ascending doses of the investigational product given to subjects negative or positive for pre-existing human anti-heavy chain variable domain (HAVH) antibodies (Cohorts 1 to 3 with Subcohorts 1a, 2a and 3a negative for HAVH and 1b, 2b, 3b positive for HAVH). Part B includes only subjects negative for HAVH, with ascending doses given to Cohorts 4 to 6. Cohort 7 receives the same dose as Cohort 6, but whereas the other Cohorts are single-blinded, Cohort 7 is open-label and additionally receives a bronchoalveolar lavage (BAL). The study consists of a Screening Visit (up to 56 days before Day 1, the day of the drug administration), Visits on Day -1, 1, 2, 3, 5, 7, 14, 28 and Follow-Up Visits on Day 57 and 85. This form is to be filled in continously during the study and/or at the follow-up evaluation and contains information on other medication the participant has received during the course of the study.
Link
https://clinicaltrials.gov/ct2/show/NCT01476046
Trefwoorden
Versies (1)
- 25-10-19 25-10-19 -
Houder van rechten
GlaxoSmithKline
Geüploaded op
25 oktober 2019
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Phase I Trial of Intravenous TNFR1 Antagonist GSK1995057 in Healthy Subjects - NCT01476046
Concomitant Medications
- StudyEvent: ODM
Beschrijving
Concomitant Medications
Alias
- UMLS CUI-1
- C2347852 (Concomitant Agent)
Beschrijving
Concomitant Medication Number
Datatype
integer
Alias
- UMLS CUI [1,1]
- C2347852 (Concomitant Agent)
- UMLS CUI [1,2]
- C0600091 (Identifier)
- SNOMED
- 118522005
- LOINC
- LP31795-5
Beschrijving
Sequence Number
Datatype
text
Alias
- UMLS CUI [1]
- C2348184 (Sequence Number)
Beschrijving
Trade Name preferred
Datatype
text
Alias
- UMLS CUI [1]
- C2360065 (Medication name)
- LOINC
- MTHU027854
Beschrijving
[hidden]
Datatype
text
Alias
- UMLS CUI [1]
- C2826819 (Concomitant Medication Modified Reported Term)
Beschrijving
[hidden]
Datatype
text
Alias
- UMLS CUI [1,1]
- C0013227 (Pharmaceutical Preparations)
- SNOMED
- 763158003
- LOINC
- LP100609-9
- UMLS CUI [1,2]
- C0871468 (Synonym)
Beschrijving
[hidden]
Datatype
text
Alias
- UMLS CUI [1,1]
- C0013227 (Pharmaceutical Preparations)
- SNOMED
- 763158003
- LOINC
- LP100609-9
- UMLS CUI [1,2]
- C1516698 (Collection (action))
- LOINC
- LP20988-9
- UMLS CUI [1,3]
- C0805701 (Code)
Beschrijving
[hidden]
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0805701 (Code)
- UMLS CUI [1,2]
- C0231175 (Failed)
Beschrijving
Concomitant Medication Unit Dose
Datatype
text
Alias
- UMLS CUI [1]
- C2826811 (Concomitant Medication Dose)
Beschrijving
Concomitant Medication Units
Datatype
text
Alias
- UMLS CUI [1]
- C2826646 (Concomitant Medication Dose Unit)
Beschrijving
Concomitant Medication Frequency
Datatype
text
Alias
- UMLS CUI [1]
- C2826654 (Concomitant Medication Dose Frequency)
Beschrijving
Concomitant Medication Route
Datatype
text
Alias
- UMLS CUI [1]
- C2826730 (Concomitant Medication Route of Administration)
Beschrijving
Concomitant Medication reason
Datatype
text
Alias
- UMLS CUI [1]
- C2826696 (Concomitant Medication Use Indication)
Beschrijving
Concomitant Medication start date/time
Datatype
partialDatetime
Alias
- UMLS CUI [1]
- C2826825 (Concomitant Medication Use Start Date Time)
Beschrijving
Concomitant Medication Taken Prior to Study?
Datatype
text
Alias
- UMLS CUI [1]
- C2826667 (Concomitant Medication Previous Occurrence)
Beschrijving
If no, specify End Date and Time
Datatype
text
Alias
- UMLS CUI [1]
- C2826666 (Concomitant Medication Ongoing)
Beschrijving
Concomitant Medication end date/time
Datatype
partialDatetime
Alias
- UMLS CUI [1]
- C2826815 (Concomitant Medication Use End Date Time)
Similar models
Concomitant Medications
- StudyEvent: ODM
C1264639 (UMLS CUI [1,2])
C0600091 (UMLS CUI [1,2])
C0871468 (UMLS CUI [1,2])
C1516698 (UMLS CUI [1,2])
C0805701 (UMLS CUI [1,3])
C0231175 (UMLS CUI [1,2])
Geen commentaren